https://www.zacks.com/stock/news/2213660/can-masimo-masi-run-higher-on-rising-earnings-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_8-2213660
Jan 22, 2024 - Masimo (MASI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
zc:-8885202545043946471
0
https://www.zacks.com/stock/news/2212913/what-s-in-store-for-edwards-lifesciences-ew-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2212913
Jan 19, 2024 - Edwards Lifesciences' (EW) Q4 results are likely to reflect continued demand for its state-of-the-art HemoSphere monitoring platform and Smart Recovery portfolio in Critical Care.
zc:-1120092263613024097
0
https://www.zacks.com/stock/news/2211533/what-s-in-store-for-boston-scientific-bsx-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2211533
Jan 17, 2024 - Boston Scientific (BSX) is expected to have witnessed strong growth of the WATCHMAN franchise in the fourth quarter, given the FDA approval of WATCHMAN FLX Pro in September.
zc:-164476386339662944
0
https://www.zacks.com/stock/news/2210710/here-s-why-you-should-retain-masimo-masi-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2210710
Jan 16, 2024 - Masimo's (MASI) R&D activities raise optimism about the stock.
zc:1469515628936410621
0
https://www.fool.com/investing/2024/01/10/apples-win/?source=iedfolrf0000001
Jan 10, 2024 - We've also got some productivity tips for the new year.
0
fool:-5674619110658337625
0
https://www.zacks.com/stock/news/2203325/apple-aapl-halts-smartwatch-sales-ban-amid-patent-dispute?cid=CS-ZC-FT-analyst_blog|company_news_tech_sector-2203325
Dec 28, 2023 - Apple (AAPL) wins a temporary reprieve in the patent battle over its smartwatches, pausing an import ban amid a legal clash with Masimo over medical tech.
zc:7004185941918148413
0
https://www.zacks.com/stock/news/2200083/masimo-s-masi-stork-baby-monitoring-system-approved-by-fda?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2200083
Dec 19, 2023 - The latest FDA clearance of Masimo's (MASI) Stork smart home baby monitoring system is likely to provide a continuous and accurate view of babies' health data.
zc:-1021011297589251001
0
https://www.zacks.com/stock/news/2196904/masimo-s-masi-ori-favored-by-study-for-pao2-information?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2196904
Dec 12, 2023 - Masimo's (MASI) latest study indicates that ORi can be a valuable tool to provide information on arterial oxygenation even during OLV.
zc:2271447790985836771
0